These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

817 related articles for article (PubMed ID: 28944403)

  • 21. Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images.
    van Timmeren JE; Leijenaar RTH; van Elmpt W; Reymen B; Oberije C; Monshouwer R; Bussink J; Brink C; Hansen O; Lambin P
    Radiother Oncol; 2017 Jun; 123(3):363-369. PubMed ID: 28506693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT.
    Brown PJ; Zhong J; Frood R; Currie S; Gilbert A; Appelt AL; Sebag-Montefiore D; Scarsbrook A
    Eur J Nucl Med Mol Imaging; 2019 Dec; 46(13):2790-2799. PubMed ID: 31482428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the performance of both machine learning models using PET and CT radiomics for predicting recurrence following lung stereotactic body radiation therapy: A single-institutional study.
    Nemoto H; Saito M; Satoh Y; Komiyama T; Marino K; Aoki S; Suzuki H; Sano N; Nonaka H; Watanabe H; Funayama S; Onishi H
    J Appl Clin Med Phys; 2024 Jul; 25(7):e14322. PubMed ID: 38436611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standardized 18F-FDG PET/CT radiomic features provide information on PD-L1 expression status in treatment-naïve patients with non-small cell lung cancer.
    Zhang R; Hohenforst-Schmidt W; Steppert C; Sziklavari Z; Schmidkonz C; Atzinger A; Kuwert T; Klink T; Sterlacci W; Hartmann A; Vieth M; Förster S
    Nuklearmedizin; 2022 Oct; 61(5):385-393. PubMed ID: 35768005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-treatment
    Ahn HK; Lee H; Kim SG; Hyun SH
    Clin Radiol; 2019 Jun; 74(6):467-473. PubMed ID: 30898382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiomic signature as a diagnostic factor for histologic subtype classification of non-small cell lung cancer.
    Zhu X; Dong D; Chen Z; Fang M; Zhang L; Song J; Yu D; Zang Y; Liu Z; Shi J; Tian J
    Eur Radiol; 2018 Jul; 28(7):2772-2778. PubMed ID: 29450713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body Composition and Radiomics From 18 F-FDG PET/CT Together Help Predict Prognosis for Patients With Stage IV Non-Small Cell Lung Cancer.
    Zhang Y; Tan W; Zheng Z; Wang J; Xing L; Sun X
    J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):906-912. PubMed ID: 37948365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
    Ghaly G; Rahouma M; Kamel MK; Nasar A; Harrison S; Nguyen AB; Port J; Stiles BM; Altorki NK; Lee PC
    Ann Thorac Surg; 2017 Oct; 104(4):1153-1158. PubMed ID: 28551047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Respiration-Averaged CT for Attenuation Correction of PET Images - Impact on PET Texture Features in Non-Small Cell Lung Cancer Patients.
    Cheng NM; Fang YH; Tsan DL; Hsu CH; Yen TC
    PLoS One; 2016; 11(3):e0150509. PubMed ID: 26930211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plausibility and redundancy analysis to select FDG-PET textural features in non-small cell lung cancer.
    Pfaehler E; Mesotten L; Zhovannik I; Pieplenbosch S; Thomeer M; Vanhove K; Adriaensens P; Boellaard R
    Med Phys; 2021 Mar; 48(3):1226-1238. PubMed ID: 33368399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy.
    Lovinfosse P; Janvary ZL; Coucke P; Jodogne S; Bernard C; Hatt M; Visvikis D; Jansen N; Duysinx B; Hustinx R
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1453-60. PubMed ID: 26830299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of experimental design on PET radiomics in predicting somatic mutation status.
    Yip SSF; Parmar C; Kim J; Huynh E; Mak RH; Aerts HJWL
    Eur J Radiol; 2017 Dec; 97():8-15. PubMed ID: 29153372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone Marrow and Tumor Radiomics at
    Mattonen SA; Davidzon GA; Benson J; Leung ANC; Vasanawala M; Horng G; Shrager JB; Napel S; Nair VS
    Radiology; 2019 Nov; 293(2):451-459. PubMed ID: 31526257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretherapy 18F-fluorodeoxyglucose positron emission tomography/computed tomography robust radiomic features predict overall survival in non-small cell lung cancer.
    Mostafa R; Abdelsamie Kandeel A; Abd Elkareem M; Nardo L; Abdelhafez YG
    Nucl Med Commun; 2022 May; 43(5):540-548. PubMed ID: 35190518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features.
    Khorrami M; Jain P; Bera K; Alilou M; Thawani R; Patil P; Ahmad U; Murthy S; Stephans K; Fu P; Velcheti V; Madabhushi A
    Lung Cancer; 2019 Sep; 135():1-9. PubMed ID: 31446979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer.
    Yang B; Zhou L; Zhong J; Lv T; Li A; Ma L; Zhong J; Yin S; Huang L; Zhou C; Li X; Ge YQ; Tao X; Zhang L; Son Y; Lu G
    Respir Res; 2021 Jun; 22(1):189. PubMed ID: 34183009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
    Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
    Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of feature harmonization on radiogenomics analysis: Prediction of EGFR and KRAS mutations from non-small cell lung cancer PET/CT images.
    Shiri I; Amini M; Nazari M; Hajianfar G; Haddadi Avval A; Abdollahi H; Oveisi M; Arabi H; Rahmim A; Zaidi H
    Comput Biol Med; 2022 Mar; 142():105230. PubMed ID: 35051856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics.
    van Timmeren JE; Carvalho S; Leijenaar RTH; Troost EGC; van Elmpt W; de Ruysscher D; Muratet JP; Denis F; Schimek-Jasch T; Nestle U; Jochems A; Woodruff HC; Oberije C; Lambin P
    PLoS One; 2019; 14(6):e0217536. PubMed ID: 31158263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicentric development and evaluation of [
    Lucia F; Louis T; Cousin F; Bourbonne V; Visvikis D; Mievis C; Jansen N; Duysinx B; Le Pennec R; Nebbache M; Rehn M; Hamya M; Geier M; Salaun PY; Schick U; Hatt M; Coucke P; Hustinx R; Lovinfosse P
    Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1097-1108. PubMed ID: 37987783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.